Molina Healthcare (MOH) Stock Forecast & Price Target

Compare

1,129 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MOH Analyst Ratings

Moderate Buy

4 Buy

3 Hold

1 Sell

Based on 8 analysts giving stock ratings to

Molina

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MOH Stock 12 Month Forecast

Average Price Target

$200.14

▲(8.70% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Molina Healthcare in the last 3 months. The average price target is $200.14 with a high forecast of $250.00 and a low forecast of $160.00. The average price target represents a 8.70% change from the last price of $184.12.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"144":"$144","190":"$190","236":"$236","282":"$282","328":"$328"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":250,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$250.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":200.14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$200.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":160,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$160.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[144,190,236,282,328],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,173.54,179.42153846153846,185.30307692307693,191.18461538461537,197.06615384615384,202.9476923076923,208.82923076923078,214.71076923076924,220.59230769230768,226.47384615384615,232.35538461538462,238.23692307692306,244.11846153846153,{"y":250,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,173.54,175.58615384615385,177.63230769230768,179.67846153846153,181.72461538461536,183.77076923076922,185.81692307692308,187.8630769230769,189.90923076923076,191.95538461538462,194.00153846153844,196.0476923076923,198.09384615384613,{"y":200.14,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,173.54,172.49846153846153,171.45692307692306,170.4153846153846,169.37384615384616,168.3323076923077,167.29076923076923,166.24923076923076,165.2076923076923,164.16615384615383,163.1246153846154,162.08307692307693,161.04153846153847,{"y":160,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":291.05,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":310.41,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":301.12,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.71,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":313.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297.35,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":306.29,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.13,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":183.25,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":192.79,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 51, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":153.06,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 55, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 42, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":173.54,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 37, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$250.00

Average Price Target$200.14

Lowest Price Target$160.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David S Macdonald

Truist Financial

Hold

―

Reiterated

01/27/26

Analysts Offer Insights on Healthcare Companies: Agilon Health (NYSE: AGL), Vera Therapeutics (NASDAQ: VERA) and Molina Healthcare (NYSE: MOH)

Lance Wilkes

Bernstein

$224

Buy

21.66%

Upside

Reiterated

01/27/26

Molina Healthcare (MOH) Receives a Buy from Bernstein

Ryan Langston

TD Cowen

$175

Hold

-4.95%

Downside

Reiterated

01/16/26

Analysts Offer Insights on Healthcare Companies: Charles River Labs (NYSE: CRL) and Molina Healthcare (NYSE: MOH)

Ann Hynes

Mizuho Securities

$220

Buy

19.49%

Upside

Reiterated

01/15/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sutro Biopharma (NASDAQ: STRO) and Molina Healthcare (NYSE: MOH)

Stephen Baxter

Wells Fargo

$165→$208

Buy

12.97%

Upside

Reiterated

01/07/26

Molina Healthcare price target raised to $208 from $165 at Wells FargoMolina Healthcare price target raised to $208 from $165 at Wells Fargo

Andrew Mok CFA

Barclays

$144→$164

Sell

-10.93%

Downside

Reiterated

01/05/26

Molina Healthcare price target raised to $164 from $144 at BarclaysMolina Healthcare price target raised to $164 from $144 at Barclays

David Windley

Jefferies

$162→$160

Hold

-13.10%

Downside

Reiterated

12/16/25

Molina Healthcare price target lowered to $160 from $162 at JefferiesMolina Healthcare price target lowered to $160 from $162 at Jefferies

Joshua Raskin

Nephron

$250

Buy

35.78%

Upside

Upgraded

12/15/25

Molina Healthcare upgraded to Buy from Hold at Nephron ResearchMolina Healthcare upgraded to Buy from Hold at Nephron Research

Erin Wright

Morgan Stanley

$204→$158

Hold

-14.19%

Downside

Reiterated

10/24/25

Molina Healthcare (MOH) Gets a Hold from Morgan Stanley

A.J. Rice

UBS

$180→$170

Hold

-7.67%

Downside

Reiterated

10/24/25

Molina Healthcare price target lowered to $170 from $180 at UBSMolina Healthcare price target lowered to $170 from $180 at UBS

George Hill

Deutsche Bank

$203→$165

Hold

-10.38%

Downside

Reiterated

10/24/25

Molina Healthcare price target lowered to $165 from $203 at Deutsche BankMolina Healthcare price target lowered to $165 from $203 at Deutsche Bank

Sarah James

Cantor Fitzgerald

$180

Hold

-2.24%

Downside

Reiterated

10/24/25

Cantor Fitzgerald Remains a Hold on Molina Healthcare (MOH)

Scott Fidel

Goldman Sachs

$207→$167

Hold

-9.30%

Downside

Reiterated

10/23/25

Goldman Sachs Reaffirms Their Hold Rating on Molina Healthcare (MOH)

Kevin Fischbeck

Bank of America Securities

$166→$155

Sell

-15.82%

Downside

Reiterated

10/23/25

Analysts Conflicted on These Healthcare Names: Abbott Laboratories (NYSE: ABT), Roche Holding AG (Other OTC: RHHVF) and Molina Healthcare (NYSE: MOH)

Jason Cassorla

Guggenheim

Hold

―

Reiterated

10/23/25

Molina Healthcare (MOH) Gets a Hold from Guggenheim

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David S Macdonald

Truist Financial

Hold

―

Reiterated

01/27/26

Analysts Offer Insights on Healthcare Companies: Agilon Health (NYSE: AGL), Vera Therapeutics (NASDAQ: VERA) and Molina Healthcare (NYSE: MOH)

Lance Wilkes

Bernstein

$224

Buy

21.66%

Upside

Reiterated

01/27/26

Molina Healthcare (MOH) Receives a Buy from Bernstein

Ryan Langston

TD Cowen

$175

Hold

-4.95%

Downside

Reiterated

01/16/26

Analysts Offer Insights on Healthcare Companies: Charles River Labs (NYSE: CRL) and Molina Healthcare (NYSE: MOH)

Ann Hynes

Mizuho Securities

$220

Buy

19.49%

Upside

Reiterated

01/15/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sutro Biopharma (NASDAQ: STRO) and Molina Healthcare (NYSE: MOH)

Stephen Baxter

Wells Fargo

$165→$208

Buy

12.97%

Upside

Reiterated

01/07/26

Molina Healthcare price target raised to $208 from $165 at Wells FargoMolina Healthcare price target raised to $208 from $165 at Wells Fargo

Andrew Mok CFA

Barclays

$144→$164

Sell

-10.93%

Downside

Reiterated

01/05/26

Molina Healthcare price target raised to $164 from $144 at BarclaysMolina Healthcare price target raised to $164 from $144 at Barclays

David Windley

Jefferies

$162→$160

Hold

-13.10%

Downside

Reiterated

12/16/25

Molina Healthcare price target lowered to $160 from $162 at JefferiesMolina Healthcare price target lowered to $160 from $162 at Jefferies

Joshua Raskin

Nephron

$250

Buy

35.78%

Upside

Upgraded

12/15/25

Molina Healthcare upgraded to Buy from Hold at Nephron ResearchMolina Healthcare upgraded to Buy from Hold at Nephron Research

Erin Wright

Morgan Stanley

$204→$158

Hold

-14.19%

Downside

Reiterated

10/24/25

Molina Healthcare (MOH) Gets a Hold from Morgan Stanley

A.J. Rice

UBS

$180→$170

Hold

-7.67%

Downside

Reiterated

10/24/25

Molina Healthcare price target lowered to $170 from $180 at UBSMolina Healthcare price target lowered to $170 from $180 at UBS

George Hill

Deutsche Bank

$203→$165

Hold

-10.38%

Downside

Reiterated

10/24/25

Molina Healthcare price target lowered to $165 from $203 at Deutsche BankMolina Healthcare price target lowered to $165 from $203 at Deutsche Bank

Sarah James

Cantor Fitzgerald

$180

Hold

-2.24%

Downside

Reiterated

10/24/25

Cantor Fitzgerald Remains a Hold on Molina Healthcare (MOH)

Scott Fidel

Goldman Sachs

$207→$167

Hold

-9.30%

Downside

Reiterated

10/23/25

Goldman Sachs Reaffirms Their Hold Rating on Molina Healthcare (MOH)

Kevin Fischbeck

Bank of America Securities

$166→$155

Sell

-15.82%

Downside

Reiterated

10/23/25

Analysts Conflicted on These Healthcare Names: Abbott Laboratories (NYSE: ABT), Roche Holding AG (Other OTC: RHHVF) and Molina Healthcare (NYSE: MOH)

Jason Cassorla

Guggenheim

Hold

―

Reiterated

10/23/25

Molina Healthcare (MOH) Gets a Hold from Guggenheim

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Molina Healthcare

3 Months

xxx

Success Rate

14/27 ratings generated profit

Average Return

-0.41%

reiterated a xxx

rating 15 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 51.85% of your transactions generating a profit, with an average return of -0.41% per trade.

1 Year

Ann HynesMizuho Securities

Success Rate

11/27 ratings generated profit

Average Return

-5.91%

reiterated a buy rating 15 days ago

Copying Ann Hynes's trades and holding each position for 1 Year would result in 40.74% of your transactions generating a profit, with an average return of -5.91% per trade.

2 Years

xxx

Success Rate

13/27 ratings generated profit

Average Return

-15.21%

reiterated a xxx

rating 15 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 48.15% of your transactions generating a profit, with an average return of -15.21% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MOH Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MOH has received 16 Buy Ratings, 37 Hold Ratings, and 1 Sell Ratings. MOH average Analyst price target in the past 3 months is 200.14.

Each month's total comprises the sum of three months' worth of ratings.

MOH Financial Forecast

MOH Earnings Forecast

Next quarter’s earnings estimate for MOH is $0.34 with a range of -$0.33 to $0.86. The previous quarter’s EPS was $1.84. MOH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year MOH has Performed in-line its overall industry.

MOH Sales Forecast

Next quarter’s sales forecast for MOH is $10.88B with a range of $10.45B to $11.29B. The previous quarter’s sales results were $11.48B. MOH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year MOH has Performed in-line its overall industry.

MOH Stock Forecast FAQ

What is MOH’s average 12-month price target, according to analysts?

Based on analyst ratings, Molina Healthcare’s 12-month average price target is 200.14.

What is MOH’s upside potential, based on the analysts’ average price target?

Molina Healthcare has 8.70% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MOH a Buy, Sell or Hold?

Molina Healthcare has a consensus rating of Moderate Buy which is based on 4 buy ratings, 3 hold ratings and 1 sell ratings.

What is Molina Healthcare’s price target?

The average price target for Molina Healthcare is 200.14. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $250.00 ,the lowest forecast is $160.00. The average price target represents 8.70% Increase from the current price of $184.12.

What do analysts say about Molina Healthcare?

Molina Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of MOH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Molina Healthcare (MOH) Stock Forecast & Price Target

MOH Analyst Ratings

MOH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Molina Healthcare

MOH Analyst Recommendation Trends

MOH Financial Forecast

MOH Earnings Forecast

MOH Sales Forecast

MOH Stock Forecast FAQ

Detailed List of Analyst Forecasts